| Host: | E. coli |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: | Supplied as a 0.22 Mu m filtered solution in 20mM Tris, 250mM NaCl, 0.5%TritonX-100, pH 8.0. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method: | < 0.1 EU/Mu g of the protein by LAL method. |
| Immunoreactivity: | Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Envelope at 2 Mu g/mL (100 Mu L/well) can bind Recombinant SARS-CoV-2 Nucleocapsid with a linear range of 1.2-41.1 ng/mL. |
| Immunogen Region: | Met1-Val75 |
| Immunogen: | Recombinant SARS-CoV-2 (2019-nCoV) Envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2 (2019-nCoV) Envelope (Accession #QHD43418.1) fused with an initial Met, a 6×His, Av |
| Immunogen Sequence: | MYSFVSEETGTLIVNSVLLF LAFVVFLLVTLAILTALRLC AYCCNIVNVSLVKPSFYVYS RVKNLNSSRVPDLLV |
| Background | Recombinant SARS-CoV-2 (2019-nCoV) Envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2 (2019-nCoV) Envelope (Accession #QHD43418.1) fused with an initial Met, a 6×His, Avi tag at the N-terminus. |
Information sourced from Uniprot.org